WHO Drug Information Vol. 16, No. 2, 2002
(2002; 91 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuHerbal Medicines
Ouvrir ce répertoire et afficher son contenuCurrent Topics
Ouvrir ce répertoire et afficher son contenuGood Clinical Practices
Ouvrir ce répertoire et afficher son contenuSafety Information
Ouvrir ce répertoire et afficher son contenuRegulatory Action
Ouvrir ce répertoire et afficher son contenuEssential Medicines
Fermer ce répertoireRecent Publications and Sources of Information
Afficher le documentGenomics and world health
Afficher le documentLegal status of traditional and complementary medicine
Afficher le documentKinetoplastid research source launched
Afficher le documentEndocrine disrupting chemicals
Afficher le documentProposed International Nonproprietary Names: List 87
 

Kinetoplastid research source launched

Kinetoplastid Biology and Disease (KBD) is an electronic publication which aims to strengthen ties between research and clinical/field applications, increasing dialogue between bench scientists, theoreticians and planners, and the professionals in the field. KBD accepts basic science, epidemiologic, public health, clinical, veterinary and agricultural papers on trypanosomiasis, leishmaniasis and related disease which meet the criteria of peer review.

The advent of KBD enables the free dissemination of scientific information about kinetoplastid diseases and their control. This is critical, since most scientific journals are not free and even the ones with cheaper subscription rates may not be accessible to researchers, clinicians, and field researchers in the poorest and affected developing countries. Moreover, the journal will serve as a focus in which the whole kinetoplastid community can participate: to educate, notify and debate about progress and direction. We hope our new journal will serve as a vehicle to promote pragmatic research and as a practical first step in tackling some of the communication difficulties that face those concerned with the eradication of these diseases.

KBD is created as peer-review journal, freely available to anyone in the world with a networked computer. KBD is published by BiomedCentral (www.biomedcentral.com), and has a world class editorial board (http://www.kinetoplastids.com/edboard/). It will be indexed by most of the major scientific indexing services such as PubMed. Articles will be available in html and.pdf formats. KBD is supported by the Vice-Presidencia de Desenvolvimento Institucional, Informacao e Comunicacao” and the “Instituto Oswaldo Cruz” of the Oswaldo Cruz Foundation. The journal is recipient of a Soros Foundation award for promoting open publishing.

In its first issue, Kinetoplastid Biology and Disease presents:

• Combating Kinetoplastid diseases, http://www.kinetoplastids.com/content/pdf/1475-9292-1-6.pdf

• Salivaria or Stercoraria? The Trypanosoma rangeli dilemma, http://www.kinetoplastids.com/content/pdf/1475-9292-1-5.pdf

• What can we hope to gain for trypanosomiasis control from molecular studies on tsetse biology ? http://www.kinetoplastids.com/content/1/1/4

• From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality. http://www.kinetoplastids.com/content/pdf/1475-9292-1-3.pdf

• PCR identification of Trypanosoma lewisi, a common parasite of laboratory rats, http://www.kinetoplastids.com/content/1/1/2

• Molecular determinants and regulation of Leish-mania virulence, http://www.kinetoplastids.com/content/1/1/1


Papers and feedback may be sent to kbd@trypanosome.com

Kinetoplastid Biology and Disease is available from: http://www.kinetoplastids.com.

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018